Procurement &supply chain management 5 th Joint International Monitoring Mission.

Slides:



Advertisements
Similar presentations
Strategies to strengthen the distribution system to improve the availability of medicine Dr Wael Inmair Director Assistant, Central Medical Supply Store,
Advertisements

Vertical versus Decentralized TB Pharmaceutical Management
Group III: Demand Forecasting
DiagnosisPrescribing Dispensing Adherence Follow-up.
Medication Management
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Dr. Samiha Baghdadi – Medical officer EMRO –STB ICIUM - Antalya November 2011.
MEDICINES SELECTION & FORMULARY MANAGEMENT
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
By Denis Kaffoko,(MSC.DE,B.STAT,PCGME) The effect of Scale up of TB-DOTS Services on Case Detections and Treatment success rates in Central Uganda.
MEDICINE USE CHALLENGES- NURSING PERSPECTIVE. PRESENTED ON 16 TH MAY, 2014 BY; ELIZABETH MUTEMI. MSc. NURSING (PEADS). OPTIMIZING MEDICINE USE TO IMPROVE.
A PRESENTATION ON NATIONAL DRUG POLICY AND SUPPLY CHAIN STRATEGIES BY JOYCE UGWU MRS Deputy Director, Drug & Vaccine Development, Federal Ministry Of Health,
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Inventory Management: Distribution, ICS, LMIS Nairobi, 21 February, 2006 Yasmin Chandani HIV/AIDS Technical Coordinator.
Management of the Tuberculosis Drug Supply Module 13 – March 2010.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
Improving Access for Quality-Assured TB Medicines and Diagnostics Dr Kaspars Lunte Team Leader Sourcing and Special Projects, GDF Copenhagen, IPC Meeting.
Access to and Management of 2 nd Line Drugs Challenges Summarized at 6 th Meeting, STB Working Group of MDR-TB September Tbilisi.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Wilbert Bannenberg SARPAM
Monitoring and Evaluation Module 12 – March 2010.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Programmatic Management of Multidrug Resistant TB (PMDT) 5 th Joint International Monitoring Mission of NTP, Thailand 23 August, 2013.
EXCELLENCE  EXPERTISE  INNOVATION TB Nurse Care Revisited: Heartland National TB Center Regional Perspective Debbie Onofre RN, BSN.
GLOBAL DRUG FACILITY Improving country access to anti-TB medicines Andrea de Lucia, GDF Team Leader 1 st line Country Support WHO/UNICEF Technical Briefing.
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Treating MDR-TB A Challenge Throughout ECA Public Health Practice II.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008.
Medicines Transparency Alliance31/10/ MeTA Zambia – Pricing Goodwell Lungu MeTA Secretary General.
Go to View > Master > Slide Master to edit Place, Month Year GLI and Global Fund focal point Feedback and updates Rachel Bauquerez.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
Securing the Supply of Condoms and Other Essential Products for HIV/AIDS Programs Tony Hudgins Yasmin Chandani John Snow Research & Training Institute.
Inventory Management: Distribution, ICS, LMIS Technical Briefing Seminar in Procurement and Supply Management for HIV, TB and Malaria Copenhagen, 1 February.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Strengths and Weaknesses of TB Drug Management Bangladesh, India, Kenya, The Philippines, and Uzbekistan.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Supply Chain Management. Nigeria: FBOs/NACA PEPFAR support for SCMI through EXIOS /FHI The CHAN formed a partnership with above to ensure adequate commodities.
Thailand Well-developed health care system 200,000 need ARV Target 50,000 on ARV 50% in Northern Thailand 50% rest of Thailand, including Bangkok.
Key Issues from DAY 2 31 st January 2006 Jane Masiga & Val Remedios.
Drug Management of Second-line anti-TB drugs through the Green Light Committee mechanism for programmes funded by the Global Fund to Fight Against AIDS,
Storage, LMIS and Inventory Management. SO………… Your forecasting is completed. Your procurement process is completed. And now you are waiting for the products.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Affordable healthcare Product Selection for TB, Malaria and HIV/AIDS Key issues for procurement IDA HIV/AIDS Group, Nienke Gruppelaar.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Development of Country-Specific Plans for TB Drug Selection and Use China, Brazil, and Indonesia.
ANTI COUNTERFEIT FROM COMMUNITY PERSPECTIVE -Estimates indicates 30% of drugs in Kenyan market are fake. -40 billion lost every year due to counterfeit.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
INTERGRATED PSM for EFFECTIVE iCCM IMPLEMENTATION ZAMBIA Regional Meeting on Scaling up iCCM February 2016 Nairobi Kenya.
WHO Medicines Work in Countries: The Kenya Example
Global Drug Facility An innovative approach to supplying anti-TB drugs
Increased access to quality TB drugs
QUALITY ASSURANCE OF PHARMACEUTICAL PRODUCTS IN RMH
Richard Laing, Kelly McGoldrick
S.D.A. CLINIC, KONKOMA, (GHANA) / WAD BOX RY 336. AHINSAN - KUMASI
Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis Thomas Moore Manager GDF Geneva, 19 November 2009.
Inventory Management: Distribution, ICS, LMIS
საქართველოს ტუბერკულოზის პროგრამა - არსებული მიღწევები და გამოწვევები
Pharmacy Sector SECTOR COMMITMENT TO END TB
Hospital pharmacy.
Strategies to Improve Drug Use
Presentation transcript:

Procurement &supply chain management 5 th Joint International Monitoring Mission

Overall observations Increased funding for procurement of anti-TB drugs; No stock outs of anti-TB drugs & lab reagents; Availability and use of anti-TB fixed dosage combination drugs (FDCs) increased since 2007; Well established Pharmacovigilliance system; Ancillary drugs available for management of ADRs; Functioning drug distribution system; Good storage practices 5 th Joint International Monitoring Mission

Challenges Fragmented procurement: NHSO, SSO, CSMBS, BTB (GF), hospitals – higher cost, un-assured quality, frequent delays; Numerous formulations/strengths procured: complicates drug management, leads to errors, stock outs and oversupply; Still limited use of FDCs: poor treatment adherence and unfavorable outcomes; Lack of pediatric anti-TB formulations; OTC dispensing of anti-TB drugs: irrational use & amplification of resistance; Large amount of drugs issued to MDR TB patient at once: amplify resistance & cause serious toxicity 5 th Joint International Monitoring Mission

1 MONTH MDR TB PATIENT TREATMENT

Recommendations Single & streamlined procurement of quality assured anti-TB medicines; Limit procurement of anti-TB medicines to essential formulations & strengths; Procure & promote use of fixed dosage combination drugs through all stakeholders & partners; Procure & avail nationwide child-friendly fixed dosage anti-TB formulations; Ban OTC dispensing of anti-TB medicines through legal sanctions; Ensure treatment enabler or observer for M/XDR TB patients 5 th Joint International Monitoring Mission

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.